WQ
PLXP

Wealth Quarterback’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Wealth Quarterback’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5K Sell
225
-190
-46% -$3.32K ﹤0.01% 607
2021
Q2 		$6K Buy
+415
New +$4.92K ﹤0.01% 600

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Quarterback's PLXP Position: Q3 2021 in Review

Wealth Quarterback reduced its PLx Pharma Inc. Common Stock (PLXP) stake by 46% in Q3 2021, selling an estimated $3.32K and leaving 225 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Wealth Quarterback first reported a position in PLXP in Q2 2021 and has held it in 2 quarters since. The position peaked at $6K in Q2 2021. 63 funds tracked by Wall St. Rank hold PLXP as of Q3 2021.

  • Wealth Quarterback held 225 shares of PLx Pharma Inc. Common Stock worth $5K as of Q3 2021.
  • Wealth Quarterback sold 190 PLx Pharma Inc. Common Stock shares in Q3 2021, an estimated $3.32K.
  • PLx Pharma Inc. Common Stock made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #607 holding.
  • Wealth Quarterback first reported a position in PLx Pharma Inc. Common Stock in Q2 2021 and has held it in 2 quarters since.
  • Wealth Quarterback's PLx Pharma Inc. Common Stock position peaked at $6K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.